Related Experiment Video
Updated: Aug 8, 2026
09:22
In Vitro Aggregation Assays Using Hyperphosphorylated Tau Protein
Published on: January 2, 2015
Interface between tauopathies and synucleinopathies: a tale of two proteins
Wendy R Galpern1, Anthony E Lang
1Movement Disorders Center, Toronto Western Hospital, Toronto, Ontario, Canada.
Annals of Neurology
|February 21, 2006
Summary
Neurodegenerative diseases like Parkinson's and Alzheimer's, traditionally viewed as distinct, show significant overlap in clinical and pathological features due to synuclein and tau protein interactions. This suggests a continuum, necessitating updated classifications and therapeutic strategies.
Area of Science:
- Neurology
- Neuroscience
- Molecular Biology
Background:
- Neurodegenerative diseases are typically classified by the abnormal accumulation of either synuclein or tau proteins.
- Traditionally, synucleinopathies (e.g., Parkinson's disease) and tauopathies (e.g., Alzheimer's disease) are considered distinct entities.
- Recent molecular and genetic findings reveal significant overlaps between these disease categories.
Purpose of the Study:
- To explore the overlapping clinical and pathological features of synucleinopathies and tauopathies.
- To highlight the molecular and genetic evidence supporting a continuum between these neurodegenerative diseases.
- To emphasize the implications of these overlaps for disease classification and therapeutic development.
Main Methods:
- Review of clinical presentations of Parkinson's disease and Alzheimer's disease, noting overlapping symptoms like dementia and parkinsonism.
- Examination of neuropathological findings, including the presence of Lewy bodies and neurofibrillary tangles in both disease types.
- Analysis of genetic data, focusing on mutations (e.g., LRRK2) and protein interactions (tau-synuclein) linking synucleinopathies and tauopathies.
Main Results:
- Clinical overlap is evident, with Parkinson's disease patients often experiencing dementia and Alzheimer's disease patients exhibiting parkinsonism.
- Neuropathological hallmarks like Lewy bodies and neurofibrillary tangles are found more frequently than expected in the opposing disease categories.
- Genetic studies and known protein interactions demonstrate a molecular interface between tau and synuclein pathology, with shared genetic factors identified.
Conclusions:
- The distinction between synucleinopathies and tauopathies is blurred by significant clinical, pathological, and genetic overlaps.
- Diseases like Dementia with Lewy bodies exemplify a continuum rather than discrete entities.
- An updated classification scheme is needed, and understanding these intersections is crucial for developing effective therapies for neurodegenerative diseases.
Related Concept Videos
01:37Neural Regulation
Digestion begins with a cephalic phase that prepares the digestive system to receive food. When our brain processes visual or olfactory information about food, it triggers impulses in the cranial nerves innervating the salivary glands and stomach to prepare for food.
03:03Amyloid Fibrils
Amyloid fibrils are aggregates of misfolded proteins. Under most circumstances, misfolded proteins are either refolded by chaperone proteins or degraded by the proteasome. However, in the case of a mutation or a disease, these proteins can accumulate to form large clusters and often further assemble to form elongated fibers, called fibrils.
Amyloid deposits were observed as early as 1639 in the liver and the spleen. In 1854, Rudolph Virchow performed iodine staining, normally used to...
Amyloid deposits were observed as early as 1639 in the liver and the spleen. In 1854, Rudolph Virchow performed iodine staining, normally used to...
02:04Protein-protein Interfaces
Many proteins form complexes to carry out their functions, making protein-protein interactions (PPIs) essential for an organism's survival. Most PPIs are stabilized by numerous weak noncovalent chemical forces. The physical shape of the interfaces determines the way two proteins interact. Many globular proteins have closely-matching shapes on their surfaces, which form a large number of weak bonds. Additionally, many PPIs occur between two helices or between a surface cleft and a polypeptide...
01:45Tail-anchoring of Proteins in the ER Membrane
Tail-anchored, or TA, proteins are estimated to make up to 3-5% of membrane proteins found in the eukaryotic cell. Such proteins have a single transmembrane domain located approximately 30 amino acid residues upstream from the C-terminal end. As a result, the signal recognition particle (SRP) cannot guide a TA protein to the ER membrane for cotranslational insertion. Hence, they are integrated into the ER membrane post-translationally using their C-terminal end as the anchor. TA proteins...
03:03Amyloid Fibrils
Amyloid fibrils are aggregates of misfolded proteins. Under most circumstances, misfolded proteins are either refolded by chaperone proteins or degraded by the proteasome. However, in the case of a mutation or a disease, these proteins can accumulate to form large clusters and often further assemble to form elongated fibers, called fibrils.
Amyloid deposits were observed as early as 1639 in the liver and the spleen. In 1854, Rudolph Virchow performed iodine staining, normally used to...
Amyloid deposits were observed as early as 1639 in the liver and the spleen. In 1854, Rudolph Virchow performed iodine staining, normally used to...
01:24Parkinson Disease ll: Pathophysiology
Parkinson disease (PD) is a progressive neurodegenerative disorder primarily affecting movement, with additional non-motor features. Its pathophysiology involves complex interactions among genetic susceptibility, environmental exposures, and cellular dysfunction, including dopaminergic neuron loss, protein aggregation, and mitochondrial impairment.Selective NeurodegenerationA key feature is the degeneration of dopaminergic neurons in the substantia nigra pars compacta, leading to reduced...